CME Group Inc. logo

CME Group Inc. (CME)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
289. 46
+3.87
+1.3551%
$
99.69B Market Cap
24.7 P/E Ratio
4.77% Div Yield
2.08M Volume
9.17 Eps
$ 285.59
Previous Close
Add Transaction
Day Range
285.95 290.2
Year Range
218.31 329.16
Want to track CME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why CME Group (CME) is a Top Dividend Stock for Your Portfolio

Why CME Group (CME) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CME (CME) have what it takes?

Zacks | 3 months ago
CME CEO Terrence Duffy says the exchange operator will sue CFTC over perpetual futures

CME CEO Terrence Duffy says the exchange operator will sue CFTC over perpetual futures

Outgoing CME CEO Terrence Duffy said in an appearance on CNBC's “Fast Money” that the exchange operator was planning on suing the Commodity Futures Trading Commission, or CFTC, over perpetual futures. Perpetual futures are like futures contracts but have no expiration date.

Cnbc | 4 months ago
CME Group's Terry Duffy to Step Down as CEO, Ceding Role to Finance Chief

CME Group's Terry Duffy to Step Down as CEO, Ceding Role to Finance Chief

The succession will mark the end of an era for the derivatives exchange, which transformed under Duffy's long run.

Wsj | 4 months ago
CME Group's Terry Duffy to Step Down as CEO; Lynne Fitzpatrick to Take Helm

CME Group's Terry Duffy to Step Down as CEO; Lynne Fitzpatrick to Take Helm

Duffy, will hand the reins to Fitzpatrick, currently president and chief financial officer, on March 1, 2027.

Wsj | 4 months ago
CME Group's Terry Duffy to step down in 2027, CFO Lynne Fitzpatrick to become CEO

CME Group's Terry Duffy to step down in 2027, CFO Lynne Fitzpatrick to become CEO

CME Group's Terry Duffy to step down in 2027, CFO Lynne Fitzpatrick to become CEO

Cnbc | 4 months ago
CME: An Extreme Session Per Decade Has Become One Per Month

CME: An Extreme Session Per Decade Has Become One Per Month

CME Group benefits from heightened volatility and record derivatives volumes, driven by regime shifts in Fed policy and persistent macro uncertainty. Recent years show a structural increase in extreme trading sessions, with open interest and leveraged basis trades reaching unprecedented levels. I assign a Buy rating to CME, as its toll-collecting model thrives amid disagreement over rates and ongoing funding guarantees from the Fed.

Seekingalpha | 4 months ago
CME Group Adds Four E-mini Futures for Broad Market Exposure

CME Group Adds Four E-mini Futures for Broad Market Exposure

CME expands its equity index futures lineup with four new E-mini contracts, targeting demand for broad-market exposure and risk management.

Zacks | 4 months ago
CME to offer 24/7 gold and oil trading

CME to offer 24/7 gold and oil trading

Geopolitical uncertainty doesn't take the weekend off, and neither will gold and oil futures as the CME prepares to launch 24/7 trading.

Kitco | 4 months ago
Is the Options Market Predicting a Spike in CME Group Stock?

Is the Options Market Predicting a Spike in CME Group Stock?

Investors need to pay close attention to CME stock based on the movements in the options market lately.

Zacks | 4 months ago
CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007' Risk

CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007' Risk

CME Group NASDAQ: CME Chairman and CEO Terry Duffy sharply criticized the Commodity Futures Trading Commission's approval of a Bitcoin perpetual futures contract for Kalshi, saying the product does not fit his view of a futures contract and raises risks for retail investors.

Marketbeat | 4 months ago
CME Group Inc. (CME) Presents at Piper Sandler Global Exchange and Fintech Conference Transcript

CME Group Inc. (CME) Presents at Piper Sandler Global Exchange and Fintech Conference Transcript

CME Group Inc. (CME) Presents at Piper Sandler Global Exchange and Fintech Conference Transcript

Seekingalpha | 4 months ago
CME Group (CME) is a Top Dividend Stock Right Now: Should You Buy?

CME Group (CME) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CME (CME) have what it takes?

Zacks | 4 months ago
Loading...
Load More